ImmuniQ

Personalized Immuno-oncology Treatment

Health Tech & Life Sciences
Active
Pre-Funding Founded 2022
Website ↗
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2022
Headcount
3
HQ
Sector
Health Tech & Life Sciences

About

ImmuniQ has developed a method for quantifing the actual and functional tumor response to immunotherapy drugs. The company’s immune checkpoint artificial reporter (IcAR) technology is able to quantify binding and shows the actual surface activity of the patient’s cancer cells, enabling more effective treatment for each patient.

Q&A

What is ImmuniQ's primary focus?
ImmuniQ is focused on personalized immuno-oncology treatment, developing a method to quantify tumor response to immunotherapy drugs.
What technology has ImmuniQ developed?
ImmuniQ has developed immune checkpoint artificial reporter (IcAR) technology, which quantifies binding and shows the actual surface activity of a patient’s cancer cells to enable more effective treatment.
When was ImmuniQ founded?
ImmuniQ was founded in January 2022.
What is ImmuniQ's current employee count?
ImmuniQ currently has 1-10 employees.
Who are the co-founders of ImmuniQ?
The co-founders of ImmuniQ include Moshe Elkabets (Co-Founder & CSO) and Angel Porgador (Co-founder & CIO).
What is ImmuniQ's current funding stage?
ImmuniQ is currently in the Pre-Funding stage.
What sector does ImmuniQ primarily operate in?
ImmuniQ primarily operates in the Health Tech & Life Sciences sector.

Team · 2

Founder · Co-Founder & CSO
LinkedIn ↗
Founder · Co-founder & CIO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

pharmaceuticalsdrug-discoveryimmunologycancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteimmuniq.tech/

Identifiers & details

Founded2022-1
Employees (exact)3

Radar intelligence

Publications (Crossref)

Works1

Web history (Wayback)

Domainimmuniq.tech

Certificate / subdomain footprint

Subdomains2